Editor's Note: the "Trending USA Stocks" column tracks the day's top bullish stocks in the USA market, aiding investors in promptly identifying opportunities for potential gains.

20/07/2026 Eastern Time in USA The Dow Jones Industrial Average dropped by 0.59%, closing at 51839.26 points; the Nasdaq Composite dropped by 0.05%, closing at 25508.07 points; the S&P 500 Index dropped by 0.19%, closing at 7443.28 points. Sahm has compiled the Top 10 Daily Stock Price Gainers in the USA market.

Zhengye Biotechnology Holding Limited: Overnight gain 1047.6%, Surges Amid Low Float, Strong Fundamentals, and Rising Animal Vaccine Sector Sentiment

**Zhengye Biotechnology Holding Limited: Corporate Profile and Business Overview** Zhengye Biotechnology Holding Limited was incorporated in the Cayman Islands on 24 March 2023 as an exempted company with limited liability. The Company conducts its principal operations through its wholly-owned Chinese subsidiary, Jilin Zhengye Biological Products Co., Ltd. (吉林正业生物制品股份有限公司), headquartered in Jilin City, Jilin Province, the People's Republic of China. The subsidiary traces its origins to the Harbin Veterinary Biological Pharmaceutical Plant under the Ministry of Agriculture, which was relocated to Jilin City in 1970, establishing an operational history spanning more than five decades. In 2004, the entity underwent a significant corporate restructuring, transitioning from the Jilin Provincial Biological Products Factory into a privately-held joint-stock enterprise. The restructured company is majority-controlled by Jilin Zhengye Group, a nationally designated leading enterprise in agricultural industrialization. The subsidiary was subsequently listed on the National Equities Exchange and Quotations (NEEQ) in 2016. As of the current reporting period, the Company operates 14 GMP-certified production lines with a diversified product portfolio comprising 43 registered product approvals and more than 80 product specifications across four categories of veterinary vaccines — covering swine, poultry, bovine and ovine, and companion animals. The Company's animal experiment center, commissioned in 2015, represents one of the first intelligent animal experimentation and testing platforms established in the PRC and remains the largest facility of its kind in Northeast China, underscoring the Company's commitment to research and development excellence and regulatory compliance.

**Zhengye Biotechnology Holding Limited (ZYBT) Surges on Confluence of Multiple Catalysts** The remarkable price appreciation in Zhengye Biotechnology Holding Limited (ZYBT) shares can be attributed to a convergence of multiple factors. First, as a low-priced micro-cap listed on Nasdaq, ZYBT carries an extremely low share price base with minimal float — July 15 trading volume registered only 5,868 shares, meaning even marginal capital inflows can generate extraordinary percentage gains, highlighting the stock's inherent price elasticity. Second, underlying fundamentals provide meaningful support: subsidiary Jilin Zhengye Biological Products boasts over 50 years of veterinary vaccine R&D expertise, 14 GMP-certified production lines, and Northeast China's largest intelligent animal research platform, with product coverage spanning swine, poultry, cattle, sheep, and companion animals. Third, sustained sector tailwinds in the animal vaccine industry, combined with rising investor sentiment toward China-concept agricultural biotech equities, have attracted concentrated short-term capital flows into ZYBT.

AMC Entertainment Holdings, Inc. Class A: Overnight gain 26.8%, Surges Amid Record Revenue, Debt Refinancing, and Meme Stock Momentum

**AMC Entertainment Holdings, Inc. – Corporate Overview** AMC Entertainment Holdings, Inc. was incorporated under the laws of the State of Delaware on June 6, 2007. Through its direct and indirect subsidiaries, including American Multi-Cinema, Inc., the Company is principally engaged in the theatrical exhibition business, owning, operating, or holding interests in movie theatres across the United States and Europe. The Company holds the distinction of being the largest theatrical exhibition company in the world and a recognized leader within the industry. The Company's primary revenue streams are derived from box office admissions and food and beverage sales. Supplemental revenue sources include screen advertising, membership fees generated through the AMC Stubs loyalty program, theatre venue rentals, gift card and exchange certificate sales, as well as online ticketing convenience fees.

**AMC Entertainment Holdings, Inc. Class A (AMC) Surges 26.8% on Record Q2 Results and Improved Balance Sheet** AMC Entertainment Holdings, Inc. Class A (AMC) shares rallied sharply, driven by a confluence of fundamental and technical catalysts. Q2 revenue reached $1.597 billion, surging 14.2% year-over-year to an all-time high in the company's 106-year history. Adjusted EBITDA soared 69.6% to $321 million, marking the first quarter exceeding $300 million, while free cash flow doubled year-over-year to $190 million. On the balance sheet, AMC completed a $400 million refinancing with a four-year maturity extension, effectively eliminating near-term debt concerns through 2029. Additionally, CNBC host Jim Cramer's bearish commentary triggered a wave of retail buying based on the widely-followed "Inverse Cramer" strategy, amplifying meme stock momentum. Technically, a golden cross formation in July reinforced the bullish trend. Combined, these factors propelled AMC shares up 26.8% in a single session, bringing year-to-date gains to 57.7%.

New Era Energy & Digital: Overnight gain 26.4%, Surges Amid AI Infrastructure Demand, Driven by Vertically Integrated Data Center Strategy

**New Era Energy & Digital, Inc. Emerges as Vertically Integrated Digital Infrastructure Developer Targeting AI Hyperscalers** New Era Energy & Digital, Inc., originally incorporated in the State of Delaware in November 2020 as a blank check company, has successfully completed a business combination and subsequent rebranding, repositioning itself as a vertically integrated, next-generation digital infrastructure and power asset developer. The Company is strategically focused on delivering accelerated data center development solutions to artificial intelligence hyperscale enterprises. Central to the Company's growth strategy is the acquisition and integration of energized land assets and the development of large-scale data center campuses. The Company's inaugural flagship project is situated within the Permian Basin, marking a significant milestone in its execution of a differentiated, power-forward infrastructure development model.

**New Era Energy & Digital (NUAI) Surges 26.4% Overnight on AI Infrastructure Momentum** Shares of New Era Energy & Digital (NUAI) posted a remarkable single-session gain of 26.4%, bringing year-to-date cumulative returns to 75.8%, driven by compelling fundamental catalysts. The rally reflects growing investor recognition of NUAI's strategic positioning as a vertically integrated operator delivering data center development services to AI hyperscalers — a segment at the epicenter of today's most coveted infrastructure buildout cycle. The company's flagship Permian Basin project leverages a distinctive "energized land plus data center campus" integrated model, offering simultaneous advantages in energy cost efficiency and deployment velocity. Critically, NUAI's closed-loop vertical integration of power assets and digital infrastructure directly addresses the industry's acute power supply constraints, establishing a differentiated competitive moat that peers struggle to replicate. This combination of strategic positioning and execution capability continues to underpin sustained institutional interest in New Era Energy & Digital (NUAI).

The Top 10 Daily Gainers in the USA market are listed as follows:

Editor's note: This content was generated by Sahm's in-house AI-enabled SaaS tool and was reviewed by our editing team. Risk and Disclaimer: The content provided above is solely for informational purposes and does not represent the views or positions of Sahm Platform. While we strive for accuracy, we cannot guarantee the authenticity or completeness of the information contained in the provided content. We strongly recommend that investors consult with a qualified investment advisor when deemed necessary. Sahm Platform neither provides investment advice nor makes any representations or warranties concerning the accuracy, reliability, or completeness of the information in the content provided above. By using Sahm Platform, you acknowledge that you have read, understood, and agreed to the terms set forth in this disclaimer.